HCN Oncology Essentials: Peds Radiotherapy | Overcoming Colon Cancer | SCLC Drug Fails | At-Home Cancer Screening | Nuts!October 29, 2021 | Oncology Hematology Practice Patterns and Recommendations for Pediatric Image-Guided Radiotherapy This Children’s Oncology Group report recommends new guidance on administering radiotherapy among children with cancer. Questions are answered around imaging protocols, dose reduction, setup correction, and adaptive therapy. Read full article Gastroenterology An Extraordinary Response: A Young Woman’s Path to Overcoming Metastatic Colon Cancer The incredible story of how a young mother of two children survived and ultimately overcame colon cancer that had spread throughout her body. Despite suffering severe anemia, diarrhea and emesis, and losing 25 pounds, this determined woman beat the odds. Read full article Internal Medicine Negative Trials Close the Book on Once-Promising SCLC Drug A once-hopeful antibody-drug conjugate for small-cell lung cancer (SCLC) failed to demonstrate a survival benefit in two large, randomized studies, and was found to be mostly toxic. The negative trial results have led to the end of a drug that was considered a promising potential antidote to deadly SCLC. Read full article Hematology/Oncology Six At-Home Cancer Screening Tests A good primer for the oncologist on several cancer screening tests that can be administered at home and help detect cancer in its earliest, most treatable stages — often before people experience symptoms. Some tests, such as a screening colonoscopy, can even treat cancer by removing abnormal cells before they become problematic. Read full article Family Medicine/General Practice Nut Consumption Associated with Survival Benefit Among Long-Term Breast Cancer Survivors Nut consumption appeared associated with higher survival rates among long-term breast cancer survivors and should be emphasized as a lifestyle factor in survivor guidelines, according to a new study published in the International Journal of Cancer. Read full article